Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Voltea is a global leader in membrane-free water purification technology, specializing in Capacitive Deionization (CapDI). The company's proprietary technology provides a tunable and sustainable solution for removing salts and total dissolved solids (TDS) from water across various applications, including residential, commercial, and industrial sectors. Voltea's systems are recognized for their high water recovery rates and energy efficiency compared to traditional desalination methods. In July 2023, Voltea was acquired by DuPont Water Solutions, a business unit of DuPont, to strengthen its portfolio of advanced water treatment technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Voltea.